Chemical Compound

Benzenesulfonamide, 4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]-; Celecoxib Imp. B (EP); Celecoxib RC B (USP); Celecoxib Related Compound B; Celecoxib Impurity B

CAS Registry Number 331943-04-5
返回搜索 申请报价
Benzenesulfonamide, 4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]-; Celecoxib Imp. B (EP); Celecoxib RC B (USP); Celecoxib Related Compound B; Celecoxib Impurity B 结构式
Primary record

Benzenesulfonamide, 4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]-; Celecoxib Imp. B (EP); Celecoxib RC B (USP); Celecoxib Related Compound B; Celecoxib Impurity B

库存
7,232 克
纯度
99.4 %
CAS
331943-04-5

化合物标识与属性

CAS
331943-04-5
PubChem CID
9951856
SMILES
CC1=CC=C(C=C1)C2=NN(C(=C2)C(F)(F)F)C3=CC=C(C=C3)S(=O)(=O)N
Canonical SMILES
Cc1ccc(-c2cc(C(F)(F)F)n(-c3ccc(S(N)(=O)=O)cc3)n2)cc1

名称与同义词

  • Celecoxib EP Impurity B
  • 331943-04-5
  • Celecoxib Related Compound B
  • Celecoxib Impurity B
  • NR89ESB5UB
  • UNII-NR89ESB5UB
  • Celecoxib impurity B CRS
  • AGN-PC-0MW7W5
  • N-De(4-sulfonamidophenyl)-N'-(4-sulfonamidophenyl) Celecoxib
  • LGIMTMFJBCXYRP-UHFFFAOYSA-N
  • C17H14F3N3O2S
  • SCHEMBL13236931
  • Celecoxib related compound B [USP]
  • DTXSID10433269
  • Celecoxib USP Related Compound B
  • BCP34326
  • MFCD21363468
  • ZINC77291217
  • CID9951856
  • FD20806
  • 4-[3-(4-methylphenyl)-5-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
  • CELECOXIB IMPURITY B [EP IMPURITY]
  • Celecoxib regio Isomer;Celecoxib Impurity B
  • DS-015772
  • FT-0666292
  • CELECOXIB RELATED COMPOUND B [USP-RS]
  • J3.370.759B
  • 4-(3-(p-Tolyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
  • CELECOXIB RELATED COMPOUND B [USP IMPURITY]
  • 4-(3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
  • 4-[3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
  • B2694-468620
  • Benzenesulfonamide, 4-(3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl)-
  • N-De(4-sulfonamidophenyl)-N'-[4-sulfonamido(phenyl-d4)]Celecoxib
  • 1346604-14-5
  • 4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide
  • 4-[3-(p-tolyl)-5-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
  • N-De(4-sulfonamidophenyl)-N'-(4-sulfonamidophenyl) Celecoxib
  • 4-[3-(4-Methylphenyl)-5-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide
  • 4-[3-(p-Tolyl)-5-(trifluoromethyl)-1H-pyrazole-1-yl]benzenesulfonamide
  • 4-[3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazole-1-yl]benzenesulfonamide
  • N-De(4-sulfonamidophenyl)-N inverted exclamation mark -(4-sulfonamidophenyl) Celecoxib
  • 2,3,5,6-Tetradeuterio-4-[3-(4-methylphenyl)-5-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
  • Benzenesulfonamide, 4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]-; Celecoxib Imp. B (EP); Celecoxib RC B (USP); Celecoxib Related Compound B; Celecoxib Impurity B